Institut Du Cancer De Montpellier - Val D'aurelle

This study tests whether combining two drugs (regorafenib and irinotecan) works better than regorafenib alone for people with metastatic colorectal cancer who have already tried all standard treatments. About 377 adults with a specific gene type will take part. The goal is to see…

This study tests whether adding a special type of chemotherapy called PIPAC (sprayed directly into the abdomen) to standard IV chemotherapy can help people with peritoneal mesothelioma live longer. The trial includes 66 adults who have not had prior treatment and cannot have surg…

This study looks at giving a single dose of radiation directly to the tumor site during breast-conserving surgery for early-stage breast cancer. It involves women aged 60 and older with small, hormone-sensitive tumors. The goal is to see if this shorter, more precise radiation ap…

This study looks at whether giving an extra dose of radiation (16Gy) to the tumor area after standard whole-breast radiation (50Gy) helps prevent breast cancer from coming back in women with ductal carcinoma in situ (DCIS). About 2004 women who had breast-conserving surgery took …

This study tests whether a new tracking system (Calypso) that follows the prostate's movement during radiation can reduce long-term side effects compared to standard image-guided radiation. About 74 men with low- or intermediate-risk prostate cancer will take part. The goal is to…

This study aims to validate a microRNA signature that could better classify thyroid nodules with uncertain results from standard needle biopsies. Researchers will compare the test results with ultrasound and final surgical tissue analysis in 71 adults. If successful, this approac…

This study tests whether adding a special yoga and physiotherapy program to standard care can lower stress in women undergoing brachytherapy for cervical cancer. About 98 women will take part, with half receiving the program and half getting usual care. The goal is to see if this…